Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/4/2018
SIETES contiene 92261 citas

 
 
 1 a 20 de 91 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Pennel PB. Prescribing antiepileptic drugs to women of reproductive age. Lancet Neurol 2018:1. [Ref.ID 102517]
2. Cita con resumen
Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F, for the EURAP study group. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 2018:1. [Ref.ID 102516]
3. Cita con resumen
Bjørk M, Riedel B, Spiqset O, Veiby G, Kolstad E, Daltveit AK, Gilhus NE. Association of folic acid supplementation during pregnancy with the risk of autistic traits in children exposed to antiepileptic drugs In utero. JAMA Neurology 2017:26 de diciembre. [Ref.ID 102193]
4. Cita con resumen
Bromley RL, Weston J, Marson AG. Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children. JAMA 2017;318:1700-1. [Ref.ID 102140]
5. Cita con resumen
Zaccara G, Giovannelli F, Giorgi FS, Franco V, Gasparini S, Tacconi FM. Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies. Br J Clin Pharmacol 2017;83:1873-9. [Ref.ID 102027]
6. Cita con resumen
Anónimo. Brivaracétam et épilepsie partielle. Prescrire 2017;37:412-3. [Ref.ID 101999]
7. Cita con resumen
Zaccara G, Giovannelli F, Giorgi FS, Franco V, Gasparini S, Benedetto U. Tolerability of new antiepileptic drugs: a network meta-analysis. Eur J Clin Pharmacol 2017;73:811-7. [Ref.ID 101994]
8. Cita con resumen
Baftiu A, Landmark CJ, Rusten IR, Feet SA, Johannessen SI, Larsson PG. Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders - A pharmacoepidemiological study and clinical implications. Eur J Clin Pharmacol 2016;72:1245-54. [Ref.ID 100799]
9. Cita con resumen
Anónimo. Pérampanel et épilepsies généralisées réfractaires. Prescrire 2016;36:492-3. [Ref.ID 100550]
10. Cita con resumen
Anónimo. Hyponatrémies d'origine médicamenteuse. Prescrire 2015;35:666-71. [Ref.ID 99717]
11. Cita con resumen
Herman AO. First 3-D printed drug product approved. Journal Watch 2015:1. [Ref.ID 99373]
12.Enlace a cita original
Ferrer P, Rafaniello C, Sabaté M, Ballarín E, Coma A, Zara C, Capuano A, Rossi F, Laporte JR, Ibáñez L. Cross-national comparison of antiepileptic drug use: Catalonia, Denmark and Norway, 2007-2011. Epidemiology Biostatistics and Public Health 2014;11:e9405-9409. [Ref.ID 98375]
13. Cita con resumen
14.Tiene citas relacionadas Cita con resumen
Anónimo. Comportements violents envers autrui sous l'effet de médicaments. Prescrire 2014;34:110-3. [Ref.ID 97126]
16. Cita con resumen
Anónimo. Perampanel: a new add-on treatment for epilepsy. Drug Ther Bull 2013;51:18-20. [Ref.ID 94860]
17. Cita con resumen
Aldea A, García Sánchez-Colomer M, Fernández Quintana E, García Sáiz M. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009. Eur J Clin Pharmacol 2012;68:1329-38. [Ref.ID 93650]
18.
Rugg-Gunn FJ, Sander JW. Management of chronic epilepsy. BMJ 2012;345:41-5. [Ref.ID 93489]
19.
Guerrini R, Zaccara G, la Marca G, Rosati A. Safety and tolerability of antiepileptic drug treatment in children with epilepsia. Drug Saf 2012;53:519-33. [Ref.ID 93347]
20.Tiene citas relacionadas Cita con resumen
Brodie MJ, Kwan P. Newer drugs for focal epilepsy in adults. BMJ 2012;344:49-54. [Ref.ID 92316]
Seleccionar todas
 
 1 a 20 de 91 siguiente >>